2020-06-22
CTBE conducted FDA Pre-Submission with the U.S, Food and Drug Administration (FDA) successfully. For Reference
CTBE conducted FDA Pre-Submission with the U.S, Food and Drug Administration (FDA) successfully. For Reference
2024-12-24
CoreTissue BioEngineering announces the renewal of its corporate website
2024-11-11
Yoji Jokura will present at ”The 62nd Annual Meeting of the Japanese Society for Artificial Organs”
2024-10-15
CTBE has been selected as a coworking member of the Japan Innovation Campus in Silicon Valley, USA.
2024-08-29
CTBE announces start of clinical trial for regenerative ligament for ACL reconstruction using decellularization technology
2024-07-30
Japanese medtech startup, CoreTissue BioEngineering, becomes first company accepted into accelerator program backed by Mitsubishi Corporation (Americas) and Fogarty Innovation